Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of C$0.13 and traded as high as C$0.14. Voyageur Pharmaceuticals shares last traded at C$0.14, with a volume of 175,500 shares trading hands.
Voyageur Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 9.80, a current ratio of 0.23 and a quick ratio of 0.84. The company has a market capitalization of C$27.16 million, a P/E ratio of -6.00 and a beta of 0.88. The stock has a 50-day moving average price of C$0.15 and a 200-day moving average price of C$0.13.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Recommended Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
